# COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene Expression

> **NCT04530500** · — · WITHDRAWN · sponsor: **University of California, Irvine**

## Conditions studied

- Covid19
- Androgen Receptor Gene Overexpression

## Interventions

- **GENETIC:** COVID-19 Androgen Sensitivity Test (CoVAST)

## Key facts

- **NCT ID:** NCT04530500
- **Lead sponsor:** University of California, Irvine
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-08-13
- **Primary completion:** 2021-12-01
- **Final completion:** 2023-12-01
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Covid pandemic prohibited us from completing study-related activities.
- **Last updated:** 2024-05-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04530500

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04530500, "COVID-19 In-vitro Diagnostic Test and Androgen Receptor Gene Expression". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04530500. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*